ResearcherMedStar HealthNo recent work listed
Paul Hendrick Sugarbaker
Matched on ORCID iD 0000-0002-2431-7366; OpenAlex author ID A5043918821.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 2
- Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol a… First author DOI 10.21037/jgo-2020-02↗
- Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data. First author DOI 10.1155/2011/161862↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Oswald Anthony Stuart · 2 shared papers, 2011–2021
- Paper Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharm… DOI 10.21037/jgo-2020-02↗
- Paper Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report o… DOI 10.1155/2011/161862↗
- Lana Bijelić · 1 shared paper, 2011
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.